ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BMTX1Y45
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerI500.AS(USD) CXE
ETF TickerI500.DE(EUR) CXE
ETF TickerI500.LS(GBP) CXE
ETF TickerI500(EUR) ETF Plus

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Swap UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BMTX1Y45

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-17BUY25,062711.880692.290 694.249USD 17,399,268 625.02
2025-11-14BUY25,062699.270686.000 687.327USD 17,225,789 624.71
2025-11-13BUY25,062713.580679.930 683.295USD 17,124,739 624.38
2025-11-12BUY47,899 681.720* 624.12
2025-11-11BUY70,736676.330651.410 653.902USD 46,254,410 623.89
2025-11-10BUY70,736665.990653.190 654.470USD 46,294,590 623.74
2025-11-07BUY70,736 657.530* 623.58
2025-11-06BUY70,736657.000641.260 642.834USD 45,471,506 623.47
2025-11-05BUY70,736646.895628.000 629.890USD 44,555,871 623.38
2025-11-04BUY70,736646.221625.140 627.248USD 44,369,025 623.36
2025-11-03BUY70,736657.460627.500 630.496USD 44,598,765 623.27
2025-10-31BUY70,736659.760645.000 646.476USD 45,729,126 623.13
2025-10-30BUY70,736664.000645.000 646.900USD 45,759,118 622.98
2025-10-29BUY47,899652.910659.980 659.273USD 31,578,516 622.84
2025-10-28BUY25,062654.480655.700 655.578USD 16,430,096 622.68
2025-10-27BUY25,062585.310586.150 586.066USD 14,687,987 622.86
2025-10-24BUY25,062577.950582.700 582.225USD 14,591,723 623.08
2025-10-23BUY25,062575.690584.000 583.169USD 14,615,381 623.32
2025-10-22BUY25,062584.740588.710 588.313USD 14,744,301 623.51
2025-10-21BUY25,062579.340582.410 582.103USD 14,588,665 623.73
2025-10-20BUY25,062576.770582.650 582.062USD 14,587,638 623.96
2025-10-17BUY25,062578.050579.040 578.941USD 14,509,419 624.19
2025-10-16BUY25,062569.170589.080 587.089USD 14,713,625 624.47
2025-10-15BUY25,062576.420584.870 584.025USD 14,636,834 624.72
2025-10-14BUY25,062572.600576.180 575.822USD 14,431,251 624.98
2025-10-13SELL-25,062557.730563.770 563.166USD -14,114,067 627.39 Profit of 1,609,457 on sale
2025-10-08BUY25,062563.860605.000 600.886USD 15,059,405 627.71
2025-10-07BUY25,062583.240591.450 590.629USD 14,802,344 627.94
2025-10-06BUY25,062585.480603.650 601.833USD 15,083,139 628.16
2025-10-03BUY25,062600.000618.010 616.209USD 15,443,430 628.31
2025-10-02BUY25,062600.000605.410 604.869USD 15,159,226 628.46
2025-10-01BUY25,062599.940615.390 613.845USD 15,384,184 628.61
2025-09-30BUY26,730562.270574.040 572.863USD 15,312,628 628.96
2025-09-29BUY28,398560.750564.910 564.494USD 16,030,500 629.33
2025-09-26BUY28,398563.900564.610 564.539USD 16,031,778 629.68
2025-09-25BUY28,398555.510579.000 576.651USD 16,375,735 630.08
2025-09-24SELL-28,398576.980577.980 577.880USD -16,410,636 632.69 Profit of 1,556,605 on sale
2025-09-18BUY43,316598.710600.000 599.871USD 25,984,012 632.88
2025-09-17BUY43,316585.500587.670 587.453USD 25,446,113 633.14
2025-09-16BUY43,316575.060579.400 578.966USD 25,078,492 633.46
2025-09-15BUY43,316572.590573.690 573.580USD 24,845,191 633.80
2025-09-12BUY43,316560.000570.000 569.000USD 24,646,804 634.21
2025-09-11BUY43,316568.200570.760 570.504USD 24,711,952 634.58
2025-09-10BUY43,316555.830560.000 559.583USD 24,238,897 635.03
2025-09-09BUY43,316556.530563.570 562.866USD 24,381,104 635.47
2025-09-08SELL-43,316558.440571.200 569.924USD -24,686,828 638.26 Profit of 2,960,005 on sale
2025-09-05BUY43,316573.380577.750 577.313USD 25,006,890 638.63
2025-09-04BUY43,316567.220581.980 580.504USD 25,145,110 639.04
2025-09-02BUY30,785577.900585.490 584.731USD 18,000,944 639.40
2025-08-29BUY18,254580.700581.250 581.195USD 10,609,134 639.74
2025-08-28BUY18,254579.610590.960 589.825USD 10,766,666 640.10
2025-08-27BUY15,840586.960597.020 596.014USD 9,440,862 640.41
2025-08-12BUY51,147556.550562.740 562.121USD 28,750,802 640.91
2025-08-11BUY88,868545.940572.580 569.916USD 50,647,296 641.48
2025-08-08BUY88,868563.000567.690 567.221USD 50,407,796 641.95
2025-08-07BUY88,868559.800565.480 564.912USD 50,202,598 642.45
2025-08-06BUY88,868555.130573.470 571.636USD 50,800,146 642.98
2025-08-05BUY88,868569.900579.820 578.828USD 51,439,288 643.43
2025-08-04BUY88,868571.540577.210 576.643USD 51,245,112 643.87
2025-08-01BUY88,868558.870583.280 580.839USD 51,618,003 644.40
2025-07-31BUY88,868545.460558.130 556.863USD 49,487,302 645.02
2025-07-30BUY88,868554.580563.590 562.689USD 50,005,048 645.59
2025-07-29BUY88,868558.150559.610 559.464USD 49,718,446 646.14
2025-07-28BUY88,868558.630567.950 567.018USD 50,389,757 646.70
2025-07-25BUY88,868563.100567.210 566.799USD 50,370,295 647.24
2025-07-24BUY88,868564.640577.730 576.421USD 51,225,380 647.77
2025-07-23BUY88,868572.390576.700 576.269USD 51,211,875 648.26
2025-07-22BUY88,868560.930563.000 562.793USD 50,014,288 648.83
2025-07-21SELL-88,868545.530552.980 552.235USD -49,076,019 651.78 Profit of 8,846,706 on sale
2025-07-18BUY88,868542.520550.890 550.053USD 48,882,111 652.51
2025-07-17BUY88,868550.000554.480 554.032USD 49,235,714 653.19
2025-07-16BUY88,868547.930558.350 557.308USD 49,526,845 653.90
2025-07-15BUY88,868547.960574.750 572.071USD 50,838,806 654.61
2025-07-14BUY88,868570.590575.130 574.676USD 51,070,307 655.18
2025-07-11BUY88,868567.740568.460 568.388USD 50,511,506 655.78
2025-07-10BUY88,868559.760566.370 565.709USD 50,273,427 656.45
2025-07-09BUY88,868552.580558.380 557.800USD 49,570,571 657.17
2025-07-08BUY88,868547.750559.460 558.289USD 49,614,029 657.93
2025-07-07BUY88,868538.110547.590 546.642USD 48,578,983 658.78
2025-07-04SELL-88,868 200.050* 662.03 Profit of 58,833,232 on sale
2025-07-03BUY88,868547.360555.000 554.236USD 49,253,845 662.85
2025-07-02BUY88,868547.740551.500 551.124USD 48,977,288 663.68
2025-06-30BUY88,868525.000526.080 525.972USD 46,742,081 664.68
2025-06-27BUY88,868521.000531.210 530.189USD 47,116,838 665.73
2025-06-26BUY88,868521.000524.520 524.168USD 46,581,763 666.79
2025-06-25BUY88,868520.290525.630 525.096USD 46,664,232 667.88
2025-06-24BUY88,868522.270527.450 526.932USD 46,827,394 668.97
2025-06-23BUY88,868511.920516.180 515.754USD 45,834,026 670.15
2025-06-20BUY88,868509.720521.310 520.151USD 46,224,779 671.36
2025-06-19BUY88,868 513.580* 672.57
2025-06-18BUY88,868513.580519.170 518.611USD 46,087,921 673.79
2025-06-17BUY88,868508.860523.010 521.595USD 46,353,105 675.07
2025-06-16BUY88,868522.680538.200 536.648USD 47,690,835 676.26
2025-06-13BUY88,868529.240529.550 529.519USD 47,057,293 677.42
2025-06-12BUY88,868521.840525.220 524.882USD 46,645,211 678.65
2025-06-11BUY88,868518.600528.370 527.393USD 46,868,361 679.93
2025-06-10BUY88,868523.530529.990 529.344USD 47,041,742 681.19
2025-06-09BUY88,868517.600518.270 518.203USD 46,051,666 682.52
2025-06-06BUY88,868493.220499.880 499.214USD 44,364,150 684.07
2025-06-05BUY88,868483.070491.770 490.900USD 43,625,300 685.74
2025-06-04BUY88,868484.930499.900 498.403USD 44,292,077 687.41
2025-06-03BUY88,868487.860501.110 499.785USD 44,414,892 689.09
2025-06-02BUY88,868490.810502.560 501.385USD 44,557,082 690.77
2025-05-30BUY88,868490.280519.780 516.830USD 45,929,651 692.48
2025-05-29BUY88,868605.390605.730 605.696USD 53,826,991 693.23
2025-05-28BUY88,868591.850606.000 604.585USD 53,728,260 694.11
2025-05-27BUY88,868603.260608.170 607.679USD 54,003,216 694.91
2025-05-26BUY88,868 588.340* 695.85
2025-05-23BUY88,868588.340591.640 591.310USD 52,548,538 696.81
2025-05-22BUY88,868596.850605.500 604.635USD 53,732,703 697.71
2025-05-21SELL-88,868604.620617.520 616.230USD -54,763,129 702.16 Profit of 7,636,563 on sale
2025-04-29BUY72,394568.910579.980 578.873USD 41,906,930 703.38
2025-04-28BUY139,452610.860614.830 614.433USD 85,683,913 704.24
2025-04-25BUY139,452602.640602.790 602.775USD 84,058,177 705.19
2025-04-24BUY144,856599.760601.280 601.128USD 87,077,002 706.18
2025-04-23BUY150,260587.850603.770 602.178USD 90,483,269 707.31
2025-04-22BUY150,260585.490587.100 586.939USD 88,193,451 708.48
2025-04-21BUY150,260561.490570.350 569.464USD 85,567,657 709.91
2025-04-18BUY150,260 563.160* 711.35
2025-04-17BUY150,260563.160564.210 564.105USD 84,762,420 712.82
2025-04-16BUY150,260549.280561.830 560.575USD 84,232,002 714.45
2025-04-15BUY150,260557.910575.200 573.471USD 86,169,754 716.03
2025-04-14BUY150,260571.060574.720 574.354USD 86,302,428 717.51
2025-04-11BUY150,260554.180555.530 555.395USD 83,453,657 719.20
2025-04-10BUY150,260546.390571.990 569.430USD 85,562,551 721.00
2025-04-09BUY150,260576.720580.730 580.329USD 87,200,232 722.51
2025-04-08BUY150,260556.810586.030 583.108USD 87,617,812 724.28
2025-04-07BUY150,260572.780591.540 589.664USD 88,602,910 725.91
2025-04-04BUY150,260573.450612.990 609.036USD 91,513,748 727.56
2025-04-02BUY150,260625.600628.000 627.760USD 94,327,217 728.68
2025-04-01BUY150,260617.000641.240 638.816USD 95,988,491 729.93
2025-03-31BUY150,260634.230640.720 640.071USD 96,177,064 731.00
2025-03-28BUY150,260637.360642.970 642.409USD 96,528,372 732.06
2025-03-27BUY150,260635.830643.430 642.670USD 96,567,593 733.17
2025-03-26BUY67,058640.140644.000 643.614USD 43,159,468 734.25
2025-03-10BUY83,202744.830748.290 747.944USD 62,230,435 743.43
2025-03-07BUY150,260707.510729.750 727.526USD 109,318,057 743.92
2025-03-06BUY67,058698.440701.000 700.744USD 46,990,491 744.55
2025-02-26BUY29,122706.940721.410 719.963USD 20,966,762 749.27
2025-02-14BUY42,100673.600684.000 682.960USD 28,752,616 751.64
2025-02-13BUY42,100674.270677.690 677.348USD 28,516,351 752.86
2025-02-12BUY42,100663.860670.980 670.268USD 28,218,282 754.30
2025-02-11BUY42,100665.460680.790 679.257USD 28,596,719 755.75
2025-02-10BUY42,100690.360719.780 716.838USD 30,178,881 756.84
2025-02-07BUY42,100710.000731.420 729.278USD 30,702,603 757.64
2025-02-06BUY42,100722.070734.270 733.050USD 30,861,406 758.25
2025-02-05BUY42,100716.720729.250 727.997USD 30,648,674 758.98
2025-02-04BUY42,100697.050709.980 708.687USD 29,835,722 760.09
2025-02-03BUY42,100666.850673.650 672.970USD 28,332,038 761.78
2025-01-31BUY42,100672.980688.000 686.498USD 28,901,566 763.43
2025-01-30BUY42,100683.080689.620 688.966USD 29,005,468 764.94
2025-01-29BUY42,100687.270697.570 696.540USD 29,324,334 766.44
2025-01-28BUY42,100686.330690.300 689.903USD 29,044,916 768.01
2025-01-27BUY42,100684.710698.450 697.076USD 29,346,900 769.67
2025-01-24BUY42,100675.790693.840 692.035USD 29,134,674 771.59
2025-01-23BUY42,100694.640696.190 696.035USD 29,303,074 773.19
2025-01-22SELL-42,100680.030699.880 697.895USD -29,381,380 784.01 Profit of 3,625,370 on sale
2025-01-21BUY42,100687.800692.930 692.417USD 29,150,755 786.10
2025-01-20BUY42,100 681.580* 788.42
2025-01-17BUY42,100681.580707.480 704.890USD 29,675,868 790.85
2025-01-15BUY42,100703.430712.600 711.683USD 29,961,853 795.26
2025-01-14BUY42,100690.870715.980 713.469USD 30,037,044 797.80
2025-01-13BUY42,100716.900717.370 717.323USD 30,199,298 799.83
2025-01-09BUY42,100 733.590* 804.28
2025-01-08BUY42,100733.590743.280 742.311USD 31,251,294 806.19
2025-01-02BUY42,100715.190726.810 725.648USD 30,549,781 808.72
2024-12-30BUY42,100702.590708.970 708.332USD 29,820,776 811.75
2024-12-10BUY42,100778.500791.490 790.191USD 33,267,041 812.73
2024-12-09BUY42,100788.000800.990 799.691USD 33,666,991 813.47
2024-12-06BUY42,100778.000778.120 778.108USD 32,758,347 814.58
2024-12-05BUY42,100767.900768.020 768.008USD 32,333,138 816.09
2024-12-04BUY42,100754.260756.130 755.943USD 31,825,201 818.15
2024-12-03BUY42,100749.570770.000 767.957USD 32,330,990 820.51
2024-12-02BUY42,100762.340763.890 763.735USD 32,153,244 822.59
2024-11-29BUY42,100750.220754.510 754.081USD 31,746,810 825.27
2024-11-28BUY42,100 754.870* 827.98
2024-11-27BUY42,100754.870762.160 761.431USD 32,056,244 830.91
2024-11-26BUY42,100753.030754.180 754.065USD 31,746,136 834.15
2024-11-21BUY42,100744.500757.560 756.254USD 31,838,293 846.72
2024-11-20BUY42,100743.350750.690 749.956USD 31,573,148 851.89
2024-11-19BUY42,100744.600758.600 757.200USD 31,878,119 857.53
2024-11-12BUY42,100821.000831.000 830.000USD 34,943,000 865.30
2024-11-11SELL-42,100825.680834.420 833.546USD -35,092,286 904.05 Profit of 2,968,377 on sale
2024-11-07SELL-42,100824.480832.530 831.725USD -35,015,624 915.70 Profit of 3,535,317 on sale
2024-10-31SELL-42,100838.200883.150 878.655USD -36,991,376 951.52 Profit of 3,067,803 on sale
2024-10-30SELL-42,100922.790935.860 934.553USD -39,344,681 954.55 Profit of 841,822 on sale
2024-10-29BUY42,100927.330932.380 931.875USD 39,231,938 958.44
2024-10-28BUY42,100928.610943.270 941.804USD 39,649,949 963.41
2024-10-24SELL-42,100928.900952.020 949.708USD -39,982,708 976.51 Profit of 1,128,364 on sale
2024-10-21SELL-42,100968.500991.240 988.966USD -41,635,468 990.68 Profit of 72,159 on sale
2024-10-18BUY42,100990.6801,002.690 1,001.489USD 42,162,687 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy